Charing Cross 2017
London, United Kingdom April 25 - April 28, 2017
Charing Cross 2017 will continue to focus on education, innovation and evidence in order to reach consensus in all aspects of vascular disease management. In all sessions CX will address “Pathways of Care”, and the audience will hear presentations in all of the vascular domains.
Launch of ADVANTA™ V12™ 32mm
Please join Getinge in celebrating the launch of the new ADVANTA™ V12™ 32mm length balloon expandable covered stent at the Charing Cross International Congress.
Visit our booth at 15:30 on Tuesday, 25th.
™ ADVANTA and V12 are trademarks or registered trademarks of Getinge AB, its subsidiaries, or affiliates in the United States or other countries.
We invite you to our workshops in cooperation with Vascular International
Join the Vascular International masterclasses in our Getinge training village. You will have the possibility to learn, in closely supervised modules, the cutting edge technology from experts in the field: the placement of a V12, a bifurcated antimicrobial graft for AAA or the latest techniques in arteriovenous accesses.
Open AAA: April 25, 14:30 - 16:30 and April 28, 9:30 - 11:30
Renal Stenting (FEVAR): April 26, 9:30 - 11:00, 12:00 - 13:30 and 15:00 - 16:30
Arteriovenous accesses: April 27, 9:30 - 11:30 and 14:30 - 16:30
Getinge satellite symposia
Getinge will host two symposia during Charing Cross:
On Thursday morning Prof. Xavier Bérard will present the striking results of the brand new INTERGARD SYNERGY data. Together with Fatima Mzali, a well-known microbiologist, and Dr. Afshin Assadian, they will explain why rifampicine soaking should stop.
On Thursday afternoon, Prof. Patrice Mwipatayi, the PI of COBEST, will demonstrate the current status and future role of balloon expandable covered stents. He will highlight the role of covered stents in aorta-iliac occlusive disease and the 5 year COBEST data. Our second speaker Dr. Louisa van Dijk will discuss mesenteric artery stenting highlighting, the brand new guidelines and update on the ongoing CoBaGi trial related to mesenteric artery stenting.
Breaking news you have to know about (endo)graft (re)infections
Date: Thursday, April 27
Time: 10:00 – 10:30
Place: Upper main auditorium
Moderator: Dr. Afshin Assadian
Rapid development of rifampicin resistance: Why soaking grafts should stop!
Dr. Fatima Mzali, Bordeaux – France
Latest evidence of the antimicrobial efficacy of INTERGARD SYNERGY grafts
Prof. Dr. Xavier Berard, Bordeaux – France
Contemporary approach to treat complex occlusive iliac and visceral lesions
Date: Thursday, April 27
Time: 15:30 – 16:00
Place: Lower main auditorium
Moderator: Prof. Dr. Eric Verhoeven
The role of covered stents in aorto-iliac occlusive disease
Prof. Dr. Patrice Mwipatayi – Australia
Mesenteric artery stenting: a covered future?
Dr. Louisa van Dijk, Rotterdam – The Netherlands